InvestSMART

VanEck Global Healthcare Leaders ETF (ASX: HLTH) - Announcements

Current share price for HLTH : $11.750 0.01 (0.09%)+

VanEck Global Healthcare Leaders ETF (HLTH) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. VanEck Global Healthcare Leaders ETF (HLTH) gives investors exposure to a diversified portfolio of the largest international companies from the global healthcare sector. Fund aims to provide investment returns before fees and other costs which track the performance of the Index.

Latest company announcements for VanEck Global Healthcare Leaders ETF (HLTH)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$52 Number of Outstanding Units as at 31 March 2021 1 Apr 2021 1:11PM $10.220 $11.750 risen by 14.97%
$52 Number of Outstanding Units as at 31 January 2021 5 Feb 2021 8:33AM $10.480 $11.750 risen by 12.12%
$52 Number of Outstanding Units as at 31 December 2021 8 Jan 2021 8:32AM $10.380 $11.750 risen by 13.20%
$52 Number of Outstanding Units as at 30 November 2020 2 Dec 2020 10:13AM $10.450 $11.750 risen by 12.44%

76 - 79 of 79 results

Page 4 of 4

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.